Cargando…

Fosfomycin Vs Ciprofloxacin as Oral Step-Down Treatment for Escherichia coli Febrile Urinary Tract Infections in Women: A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial( )

BACKGROUND: We aimed to determine the noninferiority of fosfomycin compared to ciprofloxacin as an oral step-down treatment for Escherichia coli febrile urinary tract infections (fUTIs) in women. METHODS: This was a double-blind, randomized, controlled trial in 15 Dutch hospitals. Adult women who we...

Descripción completa

Detalles Bibliográficos
Autores principales:	ten Doesschate, Thijs, Kuiper, Sander, van Nieuwkoop, Cees, Hassing, Robert Jan, Ketels, Tom, van Mens, Suzan P, van den Bijllaardt, Wouter, van der Bij, Akke K, Geerlings, Suzanne E, Koster, Ad, Koldewijn, Evert L, Branger, Judith, Hoepelman, Andy I M, van Werkhoven, Cornelis H, Bonten, Marc J M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689999/ https://www.ncbi.nlm.nih.gov/pubmed/34791074 http://dx.doi.org/10.1093/cid/ciab934

Ejemplares similares

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)
por: ten Doesschate, Thijs, et al.
Publicado: (2018)

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
por: Sobels, Annemieke, et al.
Publicado: (2022)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

Fosfomycin: Pharmacological, Clinical and Future Perspectives
por: Dijkmans, Anneke Corinne, et al.
Publicado: (2017)

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates
por: Liu, Yanyan, et al.
Publicado: (2019)

In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Treatment Duration of Febrile Urinary Tract Infections
por: van der Starre, Willize E., et al.
Publicado: (2011)

FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients—efficacy and microbiologic safety
por: Moreno, Ainhoa Fernández, et al.
Publicado: (2023)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens
por: Ortiz Zacarías, Natalia V., et al.
Publicado: (2018)

Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora
por: Lim, Do Gyeong, et al.
Publicado: (2021)

Diabetes and the Course of Febrile Urinary Tract Infection
por: van der Starre, Willize E., et al.
Publicado: (2013)

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls
por: van Werkhoven, C. H., et al.
Publicado: (2018)

Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial()
por: ten Doesschate, Thijs, et al.
Publicado: (2022)

Efficacy of Single Dose of Fosfomycin Versus a Five-Day Course of Ciprofloxacin in Patients With Uncomplicated Urinary Tract Infection
por: Hassan, Muhammad Mujeeb, et al.
Publicado: (2022)

Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study
por: Yu, Seong Hyeon, et al.
Publicado: (2022)

Recommendations for the Empirical Treatment of Complicated Urinary Tract Infections Using Surveillance Data on Antimicrobial Resistance in the Netherlands
por: Koningstein, Maike, et al.
Publicado: (2014)

Pharmacodynamics of Ceftriaxone, Ertapenem, Fosfomycin and Gentamicin in Neisseria gonorrhoeae
por: Gubenšek, Urša, et al.
Publicado: (2022)

Positive Impact of [18F]FDG-PET/CT on Mortality in Patients With Staphylococcus aureus Bacteremia Explained by Immortal Time Bias
por: van der Vaart, Thomas W, et al.
Publicado: (2023)

Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012
por: van der Steen, Matthijs, et al.
Publicado: (2015)

Duration of carriage of multidrug resistant Enterobacterales in discharged hospital and general practice patients and factors associated with clearance
por: van Weerlee, Celine, et al.
Publicado: (2020)

Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule
por: Stalenhoef, Janneke E., et al.
Publicado: (2017)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Fosfomycin and breastfeeding
Publicado: (2020)

Deimplementation strategy to reduce overtreatment of asymptomatic bacteriuria: a study protocol for a stepped-wedge cluster randomised trial
por: van Horrik, Tessa MZXK, et al.
Publicado: (2021)

Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies
por: Freitas, Daniel Melecchi de Oliveira, et al.
Publicado: (2019)

Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection
por: Stalenhoef, Janneke Evelyne, et al.
Publicado: (2019)

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies
por: van Rhee, K P, et al.
Publicado: (2022)

Negative Myoclonus Induced by Ciprofloxacin
por: van Samkar, Anusha, et al.
Publicado: (2017)

Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial
por: Koekenbier, Eva L., et al.
Publicado: (2023)

Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment
por: Buis, DTP, et al.
Publicado: (2023)

SARS-CoV-2 antibodies in employees working in non-medical contact-intensive professions in the Netherlands: Baseline data from the prospective COco-study
por: Mioch, Dymphie, et al.
Publicado: (2021)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study
por: van Nieuwkoop, Cees, et al.
Publicado: (2010)

IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis
por: Kane, Zoe, et al.
Publicado: (2021)

Renal and Splenic Infarction in a Patient with Familial Hypercholesterolemia and Previous Cerebral Infarction
por: el Barzouhi, Abdelilah, et al.
Publicado: (2018)

Urinary Proteins, Vitamin D and Genetic Polymorphisms as Risk Factors for Febrile Urinary Tract Infection and Relation with Bacteremia: A Case Control Study
por: van der Starre, Willize E., et al.
Publicado: (2015)

Injectable Bulking Agent to Treat Postprostatectomy Urinary Incontinence: A Safety and Effectiveness Pilot Study
por: van Uhm, Janneke I. M., et al.
Publicado: (2018)

Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women
por: van Nieuwkoop, Cees, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0cj4qla6uc4rgiot50s6f9nru7